Zai Lab (shanghai) Co., Ltd.
Clinical trials sponsored by Zai Lab (shanghai) Co., Ltd., explained in plain language.
-
New cancer drug trial seeks to control advanced tumors
Disease control Recruiting nowThis early-stage study is testing an experimental drug called ZL-1310 in adults with advanced solid tumors that have continued to grow despite previous treatment. The main goals are to check if the drug is safe and to see if it helps shrink tumors. About 112 people with specific …
Phase: PHASE1, PHASE2 • Sponsor: Zai Lab (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug trial aims to shrink bulging eyes in thyroid disease
Disease control Recruiting nowThis study is testing whether an investigational drug called ZL-1109 can safely reduce eye bulging and inflammation in people with active, moderate-to-severe Thyroid Eye Disease. About 99 Chinese participants will be randomly assigned to receive either the drug or a placebo for 2…
Phase: PHASE3 • Sponsor: Zai Lab (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New targeted drug trial offers hope for Tough-to-Treat lung cancer
Disease control Recruiting nowThis study is testing whether a new drug called ZL-1310 works better than standard treatments for people whose small cell lung cancer has returned after initial therapy. About 480 adults with relapsed cancer will be randomly assigned to receive either the new drug or their doctor…
Phase: PHASE3 • Sponsor: Zai Lab (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New cancer drug enters human testing for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first human study of an experimental cancer drug called ZL-6201. The main goal is to find a safe dose and see how the body processes the drug in adults with advanced sarcoma or certain other solid tumors that have stopped responding to standard treatments. Researchers…
Phase: PHASE1 • Sponsor: Zai Lab (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
New eczema treatment begins human testing
Disease control Recruiting nowThis early-stage study is testing a new drug called ZL-1503 for moderate-to-severe eczema (atopic dermatitis). Researchers will first give single doses to healthy volunteers to check safety, then give multiple doses to people with eczema to see how the body processes the drug and…
Phase: PHASE1 • Sponsor: Zai Lab (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC